What you'll learn

  • Identify the role of biomarkers in the diagnosis of adult and pediatric CNS tumors

  • Identify standard and novel treatment approaches to adult and pediatric CNS tumors

  • Recognize and address neurological complications associated with new cancer therapies

  • Discuss the role of palliative and supportive care in neuro-oncology

Course description

 This is an accredited, in-person course offered by Boston Children's Hospital, Dana-Farber Cancer Insitute, and Mass General Brigham. This course is targeted to Specialty Physicians.

Select the Take Course button to view additional information on the course registration page.

Contact ceprograms@hms.harvard.edu with questions.

You may also like

In-Person

This course will outline the National Comprehensive Cancer Network’s (NCCN) accepted guidelines, and highlight updates to staging, treatment and indications for neoadjuvant and adjuvant therapy.

Price
$50 - $150
Registration Deadline
Starts Apr 11